Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World Setting

Background: Idarucizumab has been included in guidelines for the management of bleeding or surgical procedure in dabigatran-treated patients without need for biological monitoring. The aim of the study was to assess the prognostic value of dabigatran plasma level before reversal to test the hemostat...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Front Med (Lausanne)
Main Authors: Gendron, Nicolas, Chocron, Richard, Billoir, Paul, Brunier, Julien, Camoin-Jau, Laurence, Tuffigo, Marie, Faille, Dorothée, Teissandier, Dorian, Gay, Juliette, de Raucourt, Emmanuelle, Suner, Ludovic, Bonnet, Corentin, Martin, Anne-Céline, Lasne, Dominique, Ladhari, Chayma, Lebreton, Aurélien, Bertoletti, Laurent, Ajzenberg, Nadine, Gaussem, Pascale, Morange, Pierre-Emmanuel, Le Cam Duchez, Véronique, Viallon, Alain, Roy, Pierre-Marie, Lillo-le Louët, Agnès, Smadja, David M.
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2020
Fag:
Medicine
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7772865/
https://ncbi.nlm.nih.gov/pubmed/33392223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2020.599626
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker